Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Schizophrenia (SCZ) is a complex mental disorder with onset typically in adolescence or early adulthood.
• Early neurodevelopmental disruptions, influenced by genetic factors, are implicated in SCZ susceptibility.
• Induced pluripotent stem cell (iPSC) technology enables in vitro modeling of early human brain development.

Purpose of the Study:

• To review iPSC-based studies investigating the molecular and cellular underpinnings of schizophrenia.
• To highlight how comparing iPSC-derived neurons from SCZ patients and healthy controls provides insights into disease mechanisms.
• To discuss progress and challenges in iPSC modeling for schizophrenia research.

Main Methods:

• Utilizing induced pluripotent stem cell (iPSC) technology to derive neuronal cell types.
• Comparing neuronal cells from individuals with schizophrenia (SCZ) and healthy controls.
• Analyzing differentiation, maturation, neurotransmission, mitochondrial function, and micro-RNA expression in iPSC-derived neurons.

Main Results:

• iPSC studies reveal significant alterations in neuronal differentiation and maturation in SCZ.
• Perturbations in neurotransmission, mitochondrial function, and micro-RNA expression are observed in SCZ-derived iPSC neurons.
• iPSC models recapitulate early developmental changes relevant to schizophrenia.

Conclusions:

• iPSC technology is a powerful tool for studying the early developmental basis of schizophrenia.
• Patient-specific iPSC models offer valuable insights into SCZ pathophysiology.
• Further refinement of iPSC studies is needed to advance schizophrenia research and develop targeted treatments.